Total Payments
$6,887
2024 Payments
$959.84
Companies
48
Transactions
330
Medicare Patients
9,339
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$6,260 (90.9%)
Education$626.82 (9.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,260 | 319 | 90.9% |
| Education | $626.82 | 11 | 9.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $2,012 | 89 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $545.74 | 17 | $0 (2024) |
| Amgen Inc. | $528.32 | 20 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $474.39 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $363.26 | 31 | $0 (2024) |
| UROVANT SCIENCES INC | $274.50 | 9 | $0 (2022) |
| ABBVIE INC. | $208.09 | 10 | $0 (2024) |
| Antares Pharma, Inc. | $183.79 | 10 | $0 (2024) |
| 180 Medical, Inc. | $183.25 | 10 | $0 (2022) |
| MEDIVATION FIELD SOLUTIONS LLC | $155.56 | 11 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $959.84 | 35 | Sumitomo Pharma America, Inc. ($310.93) |
| 2023 | $987.51 | 38 | Astellas Pharma US Inc ($310.41) |
| 2022 | $1,312 | 51 | Astellas Pharma US Inc ($554.60) |
| 2021 | $584.54 | 29 | Astellas Pharma US Inc ($233.46) |
| 2020 | $503.43 | 24 | Astellas Pharma US Inc ($207.29) |
| 2019 | $1,112 | 55 | Amgen Inc. ($250.05) |
| 2018 | $591.61 | 50 | Janssen Biotech, Inc. ($157.13) |
| 2017 | $835.69 | 48 | Astellas Pharma US Inc ($184.52) |
All Payment Transactions
330 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $42.94 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Oncology | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $44.83 | General |
| Category: UROLOGY | ||||||
| 09/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: UROLOGY | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Diagnostic Imaging | ||||||
| 08/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $44.33 | General |
| Category: UROLOGY | ||||||
| 08/20/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Urology Gynecology | ||||||
| 08/01/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: Immunotherapy | ||||||
| 07/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: Diagnostic Imaging | ||||||
| 07/16/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Diagnostic Imaging | ||||||
| 07/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Oncology | ||||||
| 07/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $39.58 | General |
| Category: UROLOGY | ||||||
| 06/27/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $26.08 | General |
| Category: Urology | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $38.17 | General |
| Category: UROLOGY | ||||||
| 05/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA, AKEEGA | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Oncology | ||||||
| 05/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,357 | 10,616 | $1.2M | $549,910 |
| 2022 | 30 | 2,138 | 5,115 | $809,760 | $310,436 |
| 2021 | 22 | 2,030 | 5,196 | $939,227 | $349,764 |
| 2020 | 25 | 1,814 | 4,824 | $950,011 | $323,833 |
Total Patients
9,339
Total Services
25,751
Medicare Billing
$1.5M
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 369 | 1,182 | $282,498 | $141,079 | 49.9% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 128 | 2,301 | $161,070 | $78,646 | 48.8% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 126 | 843 | $59,010 | $57,469 | 97.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 590 | $118,000 | $50,799 | 43.0% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 280 | 639 | $165,501 | $31,330 | 18.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 43 | 427 | $36,722 | $18,844 | 51.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 74 | $23,606 | $12,396 | 52.5% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 87 | 96 | $30,240 | $10,753 | 35.6% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2023 | 128 | 286 | $20,020 | $9,775 | 48.8% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 128 | 285 | $19,950 | $9,741 | 48.8% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2023 | 128 | 285 | $19,950 | $9,741 | 48.8% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 128 | 285 | $19,950 | $9,741 | 48.8% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 128 | 285 | $19,950 | $9,741 | 48.8% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 128 | 285 | $19,950 | $9,741 | 48.8% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 128 | 284 | $19,880 | $9,706 | 48.8% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2023 | 128 | 284 | $19,880 | $9,706 | 48.8% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 127 | 283 | $19,810 | $9,672 | 48.8% |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | Office | 2023 | 118 | 254 | $17,780 | $8,672 | 48.8% |
| 52204 | Biopsy of bladder using an endoscope | Office | 2023 | 14 | 17 | $17,952 | $6,725 | 37.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 67 | 93 | $26,226 | $5,539 | 21.1% |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | Office | 2023 | 64 | 160 | $11,200 | $5,502 | 49.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 42 | 44 | $14,828 | $5,047 | 34.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 25 | 30 | $10,710 | $4,410 | 41.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 371 | 1,103 | $14,339 | $4,336 | 30.2% |
| 76870 | Ultrasound scan of scrotum | Office | 2023 | 15 | 34 | $10,676 | $3,644 | 34.1% |
About Dr. David Noller, M.D
Dr. David Noller, M.D is a Urology healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922156157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Noller, M.D has received a total of $6,887 in payments from pharmaceutical and medical device companies, with $959.84 received in 2024. These payments were reported across 330 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,260).
As a Medicare-enrolled provider, Noller has provided services to 9,339 Medicare beneficiaries, totaling 25,751 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location San Jose, CA
- Active Since 01/05/2007
- Last Updated 07/09/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922156157
Products in Payments
- GEMTESA (Drug) $796.74
- Xtandi (Drug) $637.53
- XTANDI (Drug) $574.67
- PROVENGE (Drug) $491.88
- Myrbetriq (Drug) $368.52
- Prolia (Biological) $308.10
- XGEVA (Biological) $188.35
- MYRBETRIQ (Drug) $177.23
- ERLEADA (Drug) $140.60
- Erleada (Drug) $129.63
- ELIGARD (Drug) $119.03
- Nubeqa (Drug) $115.94
- LYNPARZA (Drug) $102.23
- POSLUMA (Drug) $94.34
- ZYTIGA (Drug) $93.03
- SPEEDICATH (Device) $89.06
- LUPRON DEPOT (Drug) $88.27
- XYOSTED (Drug) $84.39
- AVEED (Biological) $72.26
- PYLARIFY (Drug) $69.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in San Jose
Robert Panvini, Md, MD
Urology — Payments: $12,164
Urology $12,164
David Nudell, Md, MD
Urology — Payments: $9,505
Urology $9,505
Dr. Mark Noller, M.d, M.D
Urology — Payments: $7,319
Urology $7,319
Mr. Edward Wang, Md, MD
Urology — Payments: $3,894
Urology $3,894
Dr. Matthew Hudnall, Md, MD
Urology — Payments: $3,805
Urology $3,805
Albert Ha, Md, MD
Urology — Payments: $3,789
Urology $3,789